by Non-PVC IV bags are used for administering fluids, blood, and medications into a patient’s body in hospital settings and healthcare facilities. Non-PVC IV bags are made using materials such as polyethylene, polypropylene, and ethylene-vinyl acetate. They provide advantages such as enhanced flexibility, puncture resistance, and biocompatibility.IV solutions serve critical needs in healthcare; however, traditional PVC materials contain toxic plasticizers that can leach into fluids.
The global Non-PVC IV Bags Market is estimated to be valued at US$ 2494.04 Mn in 2023 and is expected to exhibit a CAGR of 4.2% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rising focus on sustainability and shift toward using environment-friendly alternatives in the healthcare industry is a major factor driving growth of the Global Non-PVC IV Bags Market Size. Non-PVC materials reduce exposure to toxic elements for both patients and healthcare workers. Their adoption is expected to grow substantially over the forecast period as governments and organizations emphasize on reducing dependence on single-use plastics and pollutants released from medical waste. Manufacturers are also introducing novel biopolymer formulations that provide comparable performance to PVC while ensuring enhanced safety. This transition toward “greener” solutions is expected to further support market expansion.
SWOT Analysis
Strength: Non-PVC IV bags are made from materials like polyethylene and ethylene vinyl acetate which are safer for patients and healthcare workers. They provide better chemical and physical stability compared to PVC bags.
Weakness: Non-PVC materials used in IV bags are more expensive than PVC which increases the production cost. Availability of alternative materials is also currently limited.
Opportunity: Growing awareness about health hazards of PVC and various initiatives to ban its use in medical devices provide an opportunity for non-PVC IV bag manufacturers. Increasing investments by governments and hospitals in developing countries also support market growth.
Threats: Established market dominance of PVC-based IV bags poses competition risk. Stringent regulatory norms and standards for new materials increase entry barriers.
Key Takeaways
The global non-PVC IV bags market is expected to witness high growth over the forecast period. The global Non-PVC IV Bags Market is estimated to be valued at US$ 2494.04 Mn in 2023 and is expected to exhibit a CAGR of 4.2% over the forecast period 2024 to 2031.
Regional analysis: North America currently dominates the market due to stringent regulations banning use of PVC in medical devices. Asia Pacific is expected to be the fastest growing region supported by increasing healthcare investments and growing medical devices industry.
Key players analysis: Key players operating in the non-PVC IV bags market are Al Kuwaiti Industrial Solutions, Ziligen A.S., Arabian Universal, Semperit AG Holding, Bridgestone Corporation, Schieffer Magam Industries Ltd., ContiTech AG (Continental AG), Phoenix Conveyor Belt Systems Gmbh, Derby Conveyor Belt Industry and Trade Inc., Kale Conveyor, FaBa Commercial Services, and Fenner Dunlop Conveyor Belting. Non-PVC materials gaining acceptance at global level provide opportunities for established as well as new entrants in the industry.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
